Navigation Links
Laser Therapy a New Option for Vocal-Cord Cancers
Date:5/26/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:NeuroFocus Adds Two More of the World's Leading Neuroscientists to its Advisory Board 2Health News:NeuroFocus Adds Two More of the World's Leading Neuroscientists to its Advisory Board 3Health News:Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs 2Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 2Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 3Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 4Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 5Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 2Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 3Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 4Health News:Sushi & Breastfeeding Join Birth Defects & Preterm Birth as Leading Concerns of Moms 2
Breaking Medicine Technology:Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3Sundia MediTech Appoints Dr Tong Xu as VP of Process Chemistry 12816 1Sundia MediTech Appoints Dr Tong Xu as VP of Process Chemistry 12816 2AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 1AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 2AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 3AcelRx Announces Positive Phase 2 Results from a Study of ARX 01 Sufentanil NanoTabs in Treating Post Operative Pain 4664 4Tanning Chain Offers Tips for Effective Indoor and Outdoor Exposure 50246 1Tanning Chain Offers Tips for Effective Indoor and Outdoor Exposure 50246 2